AKT1 and gastric cancer: The PI3K/Akt signaling pathway contributes to the progression of GC through epithelial-mesenchymal transition (EMT) stimulation, and resveratrol was able to inhibit Doxorubicin treatment EMT-mediated resistance by significantly reducing the Akt signaling pathway (Kiu and Nicholson, 2012).